U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
110431110431Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal ImpairmentCompletedNo Results AvailableRenal ImpairmentDrug: OTAMIXABAN (XRP0673)https://ClinicalTrials.gov/show/NCT01120314
110432110432Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)CompletedNo Results AvailableAcute Ischemic StrokeDevice: NeuroThera® Laser Systemhttps://ClinicalTrials.gov/show/NCT01120301
110433110433A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver MetastasesCompletedNo Results AvailableNeoplasms|Liver MetastasesDrug: EZN-2968https://ClinicalTrials.gov/show/NCT01120288
110434110434Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV MelanomaActive, not recruitingNo Results AvailableAcral Lentiginous Malignant Melanoma|Lentigo Maligna Malignant Melanoma|Nodular Malignant Melanoma|Recurrent Melanoma|Solar Radiation-related Skin Melanoma|Stage IV Melanoma|Superficial Spreading Malignant MelanomaDrug: gamma-secretase/Notch signalling pathway inhibitor RO4929097|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01120275
110435110435Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and GoserelinNot yet recruitingNo Results AvailableProstate CancerGenetic: gene expression analysis|Genetic: polymorphism analysis|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01120262
110436110436S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone SurgeryRecruitingNo Results AvailableKidney CancerDrug: everolimus|Other: placebohttps://ClinicalTrials.gov/show/NCT01120249
110437110437Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerActive, not recruitingNo Results AvailableProstate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate CancerDrug: Bicalutamide|Biological: Cixutumumab|Drug: Goserelin Acetate|Other: Laboratory Biomarker Analysis|Drug: Leuprolide Acetate|Other: Pharmacological Studyhttps://ClinicalTrials.gov/show/NCT01120236
110438110438Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp PsoriasisCompletedHas ResultsScalp PsoriasisDrug: LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)https://ClinicalTrials.gov/show/NCT01120223
110439110439A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart FailureCompletedHas ResultsHeart FailureDrug: JNJ-39588146 5 ng/kg/min|Drug: JNJ-39588146 15 ng/kg/min|Drug: JNJ-39588146 30 ng/kg/min|Drug: Placebo|Drug: JNJ-39588146 5, 15, or 30 ng/kg/minhttps://ClinicalTrials.gov/show/NCT01120210
110440110440Study of Effect of Exercise With Osteoporosis and Vertebral FractureCompletedHas ResultsOsteoporosis|Vertebral FractureOther: Exercise group|Other: Control Grouphttps://ClinicalTrials.gov/show/NCT01120197
110441110441A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE)Active, not recruitingNo Results AvailableBreast CancerDrug: docetaxel|Drug: paclitaxel|Drug: pertuzumab|Drug: pertuzumab-placebo|Drug: trastuzumab [Herceptin]|Drug: trastuzumab emtansinehttps://ClinicalTrials.gov/show/NCT01120184
110442110442Myocet Plus Endoxan for Older Patients With Breast CancerRecruitingNo Results AvailableBreast CancerDrug: Cyclophosphamide|Drug: Liposomal-encapsulated doxorubicinhttps://ClinicalTrials.gov/show/NCT01120171
110443110443Paclitaxel Plus Bevacizumab for Older Patients With Breast CancerRecruitingNo Results AvailableBreast CancerDrug: Bevacizumab|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT01120158
110444110444Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in MalawiCompletedNo Results AvailableMalaria in Pregnancyhttps://ClinicalTrials.gov/show/NCT01120145
110445110445Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic ConjunctivitisCompletedNo Results AvailableAllergic ConjunctivitisDrug: CsA high dose|Drug: CsA low dose|Drug: PA|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01120132
110446110446Efficacy of Calcitriol in Recent Onset Type 1 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Calcitriolhttps://ClinicalTrials.gov/show/NCT01120119
110447110447Levosimendan Administration in Neonates With Transposition of the Great ArteriesCompletedNo Results AvailableLow Cardiac Output SyndromeDrug: levosimendan|Drug: placebohttps://ClinicalTrials.gov/show/NCT01120106
110448110448Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedHas ResultsChronic Obstructive Pulmonary Disease (COPD)Drug: Aclidinium bromide 100 μg bid|Drug: Aclidinium bromide 200 μg bid|Drug: Aclidininum bromide 400 μg bid|Drug: Placebo|Drug: Formoterol 12 μg bidhttps://ClinicalTrials.gov/show/NCT01120093
110449110449Alcohol Counseling for Telephone Quitline CallersCompletedNo Results AvailableSmoking|Nicotine Dependence|Alcohol DependenceBehavioral: Practical Counseling|Behavioral: Alcohol Intervention Counselinghttps://ClinicalTrials.gov/show/NCT01120080
110450110450Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)Active, not recruitingNo Results AvailableStress Disorders, Post-TraumaticBehavioral: Intensive Treatmenthttps://ClinicalTrials.gov/show/NCT01120067
110451110451Traumatic Brain Injury Among Homeless VeteransActive, not recruitingNo Results AvailableTraumatic Brain Injury|Homelessnesshttps://ClinicalTrials.gov/show/NCT01120054
110452110452Community-based Intergenerational Oral Health StudyRecruitingNo Results AvailablePreventive Health ServicesBehavioral: motivational interviewing counseling|Behavioral: motivational interviewing counseling|Behavioral: motivational interviewing counseling|Behavioral: health educationhttps://ClinicalTrials.gov/show/NCT01120041
110453110453Campath, Calcineurin Inhibitor Reduction and Chronic Allograft NephropathyActive, not recruitingNo Results AvailableKidney TransplantationDrug: Alemtuzumab|Drug: Basiliximab|Drug: Sirolimus|Drug: Tacrolimushttps://ClinicalTrials.gov/show/NCT01120028
110454110454Diacerein as Adjuvant to Diclofenac Sodium in Indian Patients of Osteoarthritis (OA) KneeCompletedNo Results AvailableOsteoarthritis|Osteoarthritis, KneeDrug: diacereinhttps://ClinicalTrials.gov/show/NCT01120015
110455110455Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's DiseaseRecruitingNo Results AvailableAlzheimer's DiseaseDrug: Tamibarotene|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01120002
110456110456Effects of an Amino-acid Supplement on Hepatic Lipid MetabolismCompletedNo Results AvailableMetabolic SyndromeDietary Supplement: control|Dietary Supplement: Fructose+maltodextrin placebo|Dietary Supplement: amino-acid + fructosehttps://ClinicalTrials.gov/show/NCT01119989
110457110457Association Between the Menstrual Cycle and Weight LossCompletedNo Results AvailableOverweight|ObesityBehavioral: Reduced calorie diet and exercise plan|Behavioral: Different reduced calorie diet and exercise planhttps://ClinicalTrials.gov/show/NCT01119976
110458110458Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM)CompletedNo Results AvailablePreterm DeliveryDrug: 17-alpha-hydroxy-progesterone caproate, Makena®|Drug: Castor Oil (Placebo)https://ClinicalTrials.gov/show/NCT01119963
110459110459Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: NVA237 12.5 µg once daily|Drug: NVA237 25.0 µg once daily|Drug: NVA237 12.5 µg twice daily|Drug: NVA237 50.0 µg once daily|Drug: NVA237 25.0 µg twice daily|Drug: NVA237 100.0 µg once daily|Drug: NVA237 50.0 µg twice daily|Drug: Placebo to NVA237 once dailyhttps://ClinicalTrials.gov/show/NCT01119950
110460110460Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsCompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: NVA237|Drug: Tiotropiumhttps://ClinicalTrials.gov/show/NCT01119937

* Görseller ve İçerik tekif hakkına sahip olabilir